Updated July 2011

   
 

The Journal of Investigational Allergology & Clinical Immunology will consider for publication those papers directly related to allergology and clinical and experimental immunopathology.
The journal subscribes to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (henceforth the Uniform Requirements) of the International Committee of Medical Journal Editors (ICMJE): http://www.icmje.org . Further specifications follow.

The Journal will comprise the following major sections:

Original Articles. Original research papers in allergy and
immunopathology, new forms of therapy for allergic and immune
disorders, new applications of diagnostic methods, and clinical and
experimental studies on the immunopathogenesis of allergic diseases and
immune disorders are welcome. Note that a report of a case series may
be considered an original article only if there is an explicit objective that
motivated the retrospective or prospective (cohort) study, which should
include appropriate statistical treatment of the data.
Advice on appropriate sectioning of original articles can be found
in the ICMJE’s Uniform Requirements. In those requirements, it is also
recommended that certain study designs follow particular structures for
optimum reporting. Links to those specifi c recommendations can be
obtained from the ICMJE website. They are the CONSORT statement
for randomized controlled trials, the STARD statement for studies of
diagnostic accuracy, the QUOROM statement for systematic reviews
and meta-analyses of trials, the STROBE statement for observational
studies, and the MOOSE statement for systematic analyses and metaanalyses of observational studies.

Practitioner’s Corner. These short papers, which are intended for
rapid publication, follow the same structures as longer original articles
described above but do not use subheadings or include an abstract. The
text is strictly limited to less than 1000 words (please supply a word
count), up to 10 references, 1 fi gure or table, and up to 5 key words.

Editorials and Review Articles. Contributions from specialists in the
fi eld are requested by the Editors. Unsolicited reviews will be subject
to consideration by the Editorial Board or subject to peer review at the
Board’s discretion.

Letters to the Editor. Comments on articles published in J Investig
Allergol Clin Immunol are welcome. The letter will be sent to the author
of the related article, who will have 4 weeks to answer. After the reply,
no further correspondence will be accepted. Letters will be reviewed by
the Editorial Board or subject to peer review at the Board’s discretion.

Submission of Manuscripts

Manuscripts can be submitted as a Microsoft Word file or a rich text format (RTF) fi le at the website: http://recyt.fecyt.es/index.php/JIACI/index . File names should include the corresponding author’s surname.
Each figure should be in a separate document, and the file name for each should include the corresponding author’s surname and a key word that indicates the fi gure number and manuscript it pertains to.

Author Assurances. A cover letter requesting review by the Editorial Board for publication in the journal should accompany the manuscript and include a statement by the authors(s) confi rming that the manuscript has not been published elsewhere and is not under consideration for publication elsewhere, as well as a statement of consent from all the authors.
Conflicts of interest. Authors must disclose any fi nancial or personal relationship which could result in a confl ict of interest with regard to the published article. Even if the authors consider that there is none, they must declare it.
All manuscripts accepted for publication remain the property of theJ Investig Allergol Clin Immunol and are subject to copyright restrictions regarding reproduction. Manuscripts published in or submitted to another journal cannot be considered.

Preparation of Manuscripts
Manuscripts should be typewritten, double-spaced with ample margins on all sides, and with numbered pages, following the ICMJE Uniform Requirements. The word limits for the body of the text, not including abstract, figure legends, or references are as follows: original articles, 3500 words; reviews 5000 (exceptionally up to 7500 words could
be accepted); short communications, brief case notes and letters, 1000. (Please supply a word count on the title page.)

Title Page. The first page should contain the full title, a brief running title
(not to exceed 40 characters), full name of author(s), institutional affi liation
of author(s), and name, mailing address, fax and e-mail of the author to
whom all correspondence should be directed. Note the word count and the
number of tables and fi gures. If data have been presented in abstract or poster form at conferences, this information should be noted after the title page, as should funding sources for the study or any author conflicts of interest.

Abstract
. Original articles, and reviews require abstracts. The major
points of the article should be summarized in to 250 words (original
and review articles), in the order of their appearance in the manuscript.
Material or facts not cited in the full manuscript should not be included in
the abstract. The abstract of an original article should be organized with the
following subheadings: Background (optional), Objective(s), Methods (or
Material and Methods or Patients and Methods, as appropriate), Results,
Conclusion(s). Such structuring is unnecessary for reviews.
Key Words. Three to 8 key words or brief phrases should be
included after the abstract for indexing purposes. The Medical Subject
Headings used by the US National Library of Medicine’s Index Medicus
(MEDLINE) are preferred.

Main Text.
For original articles, authors should follow the ICMJE
Uniform Requirements for structuring their articles into sections and
subsections, as mentioned above.

Tables
. Each table should be typed on a separate page after the
references. Authors are requested, whenever possible, to construct tables
that can be arranged on the page and read in the same direction as the
text. Titles should not exceed 2 lines. Information appearing in fi gures or
text should not be included in tables.

Figures
. Figures should illustrate important results, and they should
be cited in the text. Line artwork (such as graphs) should be submitted as
TIFF files, with a minimum resolution of 800 dpi. Other artwork (such as
photographs) should be submitted as 250-300 dpi TIFF fi les. Legends should be included on a separate page in the manuscript, after the references.

Acknowledgments
. When necessary, credit should be given to
persons, centers, or foundations that have collaborated in the study.
Please also acknowledge help received in preparation of the manuscript
(editing services, translation, or other) or statistical analysis. Refer to
advice in the ICMJE’s Uniform Requirements.

References
. All references should be numbered consecutively
throughout the text and enclosed in square brackets placed before
punctuation. Journal abbreviations in the reference list should be those
of the US National Library of Medicine’s Index Medicus. (See a few
examples below.) Complete citation of all the author(s) name(s) should
be followed by the complete title of the paper, abbreviated journal title,
year, volume, and fi rst and last page number. When citing a chapter from
a book, the author(s) name(s) should be followed by the complete title of
the paper, title of the book, volume number, editor(s) name(s), address and
name of the publisher, year, and fi rst and last page numbers: References
(with the exception of review articles) should be limited to approximately
35 for original articles and approximately 10 for the Practitioner’s Corner.
Authors should not submit manuscripts in which Microsoft Word
footnoting tools have been used to insert references; if other reference
management software is used, authors should remove the hyperlinks
before submitting the manuscript.
Following are 3 examples of reference presentation forms. For
additional examples, see the US National Library of Medicine’s complete
list: http://www.nlm.nih.gov/bsd/uniform_requirements.html .

1. Parameswaran K, Radford K, Zuo J, Janssen LJ, O’Byrne PM,
Cox PG. Extracellular matrix regulates human airway smooth
muscle cell migration. Eur Respir J. 2004;24:545-51.

2. Global Initiative for Asthma. Global Strategy for Asthma
Management and Prevention NIH Pub. No 02-3659, January
1995. Updated 2005. [cited 2006 Oct 24]. Available from: www.
ginasthma.com.

3. Marsh DG. Genetic and molecular analysis of human immune
responsiveness to allergens. In: Marsh DG, Lockhart A,
Holgate ST, editors. The genetics of asthma. Oxford: Blackwell
Scientifi c Publications; 1993. p. 201-13.
 

Copyediting and Proofreading
The corresponding author will be contacted by a copyeditor while the manuscript is being prepared for publication, so that the author can approve any modifi cations suggested. Furthermore, the corresponding author will receive the copyedited manuscript by e-mail with proposed modifications marked on the fi le, for approval or correction. This process
should ensure that the manuscript is both correct and readable, to the author’s satisfaction. If the author is unavailable during this process, publication delay may result.
A minimal number of changes should be necessary on page proofs, which will be sent to the same corresponding author a few weeks later.
Proofs, particularly tables and fi gures, should be checked against the original manuscript. Authors will be charged for major alterations in the original text, so attention should be given during the copyediting phase. Proofs not returned in time to meet the publication date will either be rescheduled or published without the authors’ corrections, in which case the Editors do not assume responsibility for any errors that might have been made in typesetting.

   

Top